A narrative review synthesizes the collagen biology behind vaginal laxity and the early clinical evidence for recombinant ...

As biotechnology becomes more routine, biosafety practices should account for what can persist after disposal—not only what gets inactivated.” — Tae Seok Moon ...

The host cell system is a critical determinant of recombinant protein quality and yield, with direct influence on protein folding and post-translational modification factors that shape the ...

Antibody therapeutics are among the most promising treatment modalities today, with more than 100 monoclonal antibody (mAb) therapies currently approved and thousands of ongoing preclinical and ...

Genomic surveillance in India has identified the second known recombinant mpox virus combining Clade Ib and IIb genomes, ...

A recombinant protein is a protein made by genetically engineered cells rather than extracted directly from its natural source. Scientists insert the gene for the desired protein into a production ...

Polyclonal antibodies recognize multiple epitopes and give strong signals, but every new batch comes from a different immune response, so lot-to-lot variability is built in. Hybridoma monoclonals are ...

Antibodies are now established as therapeutics and indispensable in the research lab. In con-trast to high-quality therapeutics, commercial antibodies used in research often do not proper-ly function, ...

In 1976, the prospect of genetic engineering research in local laboratories set off a historic debate among scientists and concerned citizens.